BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 27
• 29
• 30
• 31

• FDA

  Novo Nordisk A/S Receives FDA Approval for Norditropin(R) FlexPro(R) for Growth Hormone Treatment

  March 3, 2010

   · 

  2 min read
• Deals

  Pfizer Inc. (JOBS) Reportedly to Offer $4.1 Billion for Ratiopharm

  March 3, 2010

   · 

  1 min read
• Drug Development

  PTC Therapeutics, Inc. and Genzyme Corporation Announce Preliminary Results from the Phase 2b Clinical Trial of Ataluren; Primary Endpoint Does Not Reach Statistical Significance within Duration of Study

  March 3, 2010

   · 

  7 min read
• BioMS Medical Reports Spectral Diagnostics Receives FDA Approval to Initiate Pivotal Trial and Closes Financing for $19.5 Million

  March 3, 2010

   · 

  3 min read
• Genetown

  Tantaline Inc. Gains Approval from FDA

  March 3, 2010

   · 

  1 min read
• VUCC PTY LTD Announces Lodgement in Germany of Patent for Treatment of Type I Diabetes

  March 3, 2010

   · 

  1 min read
• Business

  Cleveland HeartLab LLC Raises $3 Million

  March 3, 2010

   · 

  1 min read
• Business

  Airgas and Case Western Reserve University Sign Seven-Year Supply Agreement

  March 3, 2010

   · 

  1 min read
• Pharm Country

  Zenith Biotech Introducing Novel StemQ(R) Hepatic and Neural Models

  March 3, 2010

   · 

  2 min read
• Policy

  Ranbaxy Laboratories Unable to Launch New Generic, Flomax; Shares Fall

  March 3, 2010

   · 

  1 min read